FTSJ1 Inhibitor Collaboration

About Synfini

Synfini is a private, pre-revenue platform company building an integrated AI and robotics-driven foundry for small-molecule drug discovery. Its technology aims to bridge the critical gap between in-silico molecular design and physical synthesis and testing, offering services and hosted AI models to external researchers and running internal discovery programs. Recent milestones include securing $8.9 million in discovery funding, being assessed as 'Awardable' for DARPA's ERIS Marketplace, and opening cloud access to its platform, positioning it as a emerging player in the AI-driven biotech space.

Therapeutic Areas

Other Cancer Drugs